- Report
- April 2024
- 135 Pages
Global
From €3746EUR$3,899USD£3,221GBP
- Report
- June 2022
- 300 Pages
Global
From €3459EUR$3,600USD£2,974GBP
- Report
- June 2022
- 118 Pages
Asia Pacific
From €1441EUR$1,500USD£1,239GBP
- Report
- May 2022
- 270 Pages
Global
From €3430EUR$3,570USD£2,950GBP
The Apheresis Platelet market is a subset of the Blood Banking industry. It involves the collection of platelets from a donor's blood, which are then used to treat patients with low platelet counts. Platelets are a key component of the clotting process, and are essential for preventing and treating bleeding disorders. Apheresis Platelet collection is a safe and efficient way to collect platelets from a donor, and is often used in cases where a patient needs a large number of platelets.
Apheresis Platelet collection is a highly regulated process, and requires specialized equipment and trained personnel. The equipment used in the process is typically expensive, and the cost of collection is often passed on to the patient.
Companies in the Apheresis Platelet market include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, and Fenwal Inc. Show Less Read more